Data Sheet 1_3M-052: Mouse Model Data on Combination Immunotherapy for Colon Cancer

A research document describes a study on combination immunotherapy for colon cancer using a mouse model. The study, authored by Qianyu Jing, was last updated on June 3, 2026. It details the effects of combining the TLR7/8 agonist 3M-052 with an inhibitory anti-TNFR2 antibody on tumor growth and immune cell populations.

Use Cases

• Analyzing the synergistic effects of combination immunotherapy based on tumor growth measurements.
• Modeling immune cell infiltration dynamics based on CD8+ T cell and regulatory T cell (Treg) levels.
• Studying the induction of long-term immune memory based on central memory T cell (Tcm) differentiation data.

Strengths

• The study design includes four distinct treatment groups for comparative analysis.
• Specific immune cell types, such as CD8+ T cells and Tregs, are identified as key measured variables.
• The document is licensed under CC-BY-4.0, permitting open sharing and adaptation.

Limitations

• The dataset is a 566.4 KB DOCX file, which is a small document rather than a structured data table.
• Column-level documentation and sample data are unavailable, requiring manual inspection after download.
• Row count is unknown, which may limit suitability assessment for quantitative analysis.

Provenance

Source

figshare, author Qianyu Jing

Collection Method

Data likely originates from a controlled laboratory experiment involving a colon cancer mouse model and flow cytometry analysis.

Freshness

Last updated 2026-06-03 06:07:04; freshness should be verified.